Predicting nasopharyngeal carcinoma patient response to radiation therapy

November 25, 2013

Nasopharyngeal carcinoma (NPC) affects cells lining the nasopharynx. The majority of NPC cases can be cured by radiation therapy, however ~20% are resistant to radiation treatment.

In this issue of the Journal of Clinical Investigation, Yu-Sun Chang and colleagues at Chang Gung University sought to find a way to predict which individual cases of NPC would be sensitive to radiation therapy. The authors compared the levels of various serum factors between NPC patients that responded to radiation therapy and patients that were resistant to therapy. Patients that did not respond to radiation therapy had higher serum levels of the IL-6 family cytokine leukemia inhibitory factor (LIF), and that LIF levels were predictive of NPC patient response to radiation therapy. The researchers further demonstrated that LIF itself promotes NPC.

In the companion commentary, Micah Luftig from the Duke University School of Medicine discusses the implications of LIF as a predictor of NPC resistance to .

Explore further: New finding is potential predictor of deadly cancer common in Asia

More information: Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance, J Clin Invest. DOI: 10.1172/JCI63428
Heavy LIFting: tumor promotion and radioresistance in NPC, J Clin Invest. 2013;123(12):4999–5001. DOI: 10.1172/JCI73416

Related Stories

Surgeons support nonphysician screens for low back pain

April 12, 2013

(HealthDay)—Most spine surgeons are interested in a nonphysician clinician (NPC) model of care for screening of low back or low back-related leg pain for patients referred for a surgical assessment, according to a study ...

Recommended for you

The growing menace of HPV‑related throat and mouth cancers

February 2, 2016

There's a new cancer epidemic on the rise. It's an aggressive throat and mouth cancer caused by the human papillomavirus (HPV)—the same sexually transmitted virus that leads to cervical cancer—but it's affecting mostly ...

How gut inflammation sparks colon cancer

February 4, 2016

Chronic inflammation in the gut increases the risk of colon cancer by as much as 500 percent, and now Duke University researchers think they know why.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.